Biography and Research Information
OverviewAI-generated summary
Stephen A. Fagot's research focuses on understanding the pharmacological effects of substances, particularly in the context of neurological and behavioral conditions. His work investigates the potential of substances like MDMA and novel MDXX analogues as therapeutic agents for Autism Spectrum Disorder (ASD). Fagot also examines the impact of psychostimulants on locomotor activity in mouse models, with implications for understanding comorbidities such as ASD and Attention Deficit Hyperactivity Disorder (ADHD).
His scholarship includes two publications and has garnered 8 citations, with an h-index of 1. Fagot collaborates with researchers at the University of Arkansas for Medical Sciences, including William E. Fantegrossi and Hannah E. Shaw, who have co-authored multiple publications with him.
Metrics
- h-index: 1
- Publications: 2
- Citations: 8
Selected Publications
-
Effects of psychostimulants on locomotor activity in the BTBR T+ Itpr3tf/J mouse: implications for comorbid autism spectrum disorder and attention deficit hyperactivity disorder (2025)
-
Balancing Therapeutic Efficacy and Safety of MDMA and Novel MDXX Analogues as Novel Treatments for Autism Spectrum Disorder (2023)
Collaboration Network
Top Collaborators
- Balancing Therapeutic Efficacy and Safety of MDMA and Novel MDXX Analogues as Novel Treatments for Autism Spectrum Disorder
- Effects of psychostimulants on locomotor activity in the BTBR T+ Itpr3tf/J mouse: implications for comorbid autism spectrum disorder and attention deficit hyperactivity disorder
- Balancing Therapeutic Efficacy and Safety of MDMA and Novel MDXX Analogues as Novel Treatments for Autism Spectrum Disorder
- Effects of psychostimulants on locomotor activity in the BTBR T+ Itpr3tf/J mouse: implications for comorbid autism spectrum disorder and attention deficit hyperactivity disorder
- Balancing Therapeutic Efficacy and Safety of MDMA and Novel MDXX Analogues as Novel Treatments for Autism Spectrum Disorder
- Effects of psychostimulants on locomotor activity in the BTBR T+ Itpr3tf/J mouse: implications for comorbid autism spectrum disorder and attention deficit hyperactivity disorder
- Balancing Therapeutic Efficacy and Safety of MDMA and Novel MDXX Analogues as Novel Treatments for Autism Spectrum Disorder
- Balancing Therapeutic Efficacy and Safety of MDMA and Novel MDXX Analogues as Novel Treatments for Autism Spectrum Disorder
- Balancing Therapeutic Efficacy and Safety of MDMA and Novel MDXX Analogues as Novel Treatments for Autism Spectrum Disorder
- Effects of psychostimulants on locomotor activity in the BTBR T+ Itpr3tf/J mouse: implications for comorbid autism spectrum disorder and attention deficit hyperactivity disorder
Similar Researchers
Based on overlapping research topics